Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma
✍ Scribed by O. Parolini; B. Kagerbauer; I. Simonitsch-Klupp; P. Ambros; U. Jaeger; G. Mann; O. Haas; M. Morra; H. Gadner; C. Terhorst; W. Knapp; W. Holter
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 89 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Coded sera from 54 patients with African Burkitt's lymphoma (BL) were titrated for antibodies against an Epstein‐Barr virus (EBV)‐induced membrane antigen in the antibody‐dependent cellular cytotoxicity (ADCC) assay. The titers were then correlated with the progression of lymphoma growt
A 44-year-old man infected with human immunodeficiency virus had Hodgkin's disease, mixed cellularity, and malignant non-Hodgkin's lymphoma, diffuse large cell type. Colorimetric in-situ hybridization showed the Epstein-Barr virus (EBV] genome in the cells of the large cell non-Hodgkin's lymphoma an
## Abstract The role of Epstein‐Barr virus (EBV) in Hodgkin's lymphoma (HL) etiology remains unresolved as EBV is detected in only some HL tumors and few studies have tried to reconcile its presence with factors suggesting viral etiology (__e.g.,__ childhood social class, infection history). In a p
## Abstract ## Introduction Classical Hodgkin's Lymphoma (cHL) has been frequently associated with Epstein–Barr virus (EBV), which can be found in a latent pattern in Reed‐Sternberg (RS) cells. However, the impact of the presence of EBV in RS cells and its prognosis are still controversial. We ana